Publications by authors named "Mark Lowenberg"

Claim this Profile
I
Immunogenicity and Efficacy of Subcutaneous Infliximab Monotherapy vs Combination Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Suzanne I Anjie, Krisztina B Gecse, Chiara M Meloni, Andrés Vidal-Itriago, Mark Löwenberg

Clin Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study.
Geert R D'Haens, Mark Löwenberg, Filip Baert, Peter Bossuyt, Tamás Molnár

Lancet Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of intestinal ultrasound and shear-wave elastography to assess early response in ulcerative colitis patients treated with filgotinib.
Maarten Jan Pruijt, Christoph Teichert, Floris Antonius De Voogd, Reimer Jacques Janssen, Mark Löwenberg

J Crohns Colitis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards tailored surveillance strategies in inflammatory bowel disease: still a long way to go.
José Luis Rueda García, Mark Löwenberg

J Crohns Colitis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability-enhancing strategies.
Daan W Huntjens, Olivier J M Béquignon, Stefanie D Krens, Mark Löwenberg, Martine E D Chamuleau

Br J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease.
Suzanne I Anjie, Geert R D'Haens, Filip Baert, Peter Bossuyt, Frank Hoentjen

Inflamm Bowel Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring Fatigue and Heart Rate Variability Using A Wearable Patch in Ulcerative Colitis Patients: A Cross-Sectional Pilot Study.
Paula I Metselaar, Mees J van der Hoff, Tim J van den Broek, Regina J M Kamstra, Natallia E Uzunbajakava

J Clin Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug repurposing approach for the discovery of therapeutic agents for Crohn's disease-associated intestinal fibrosis.
Dimitrios Nikolakis, Andrew Y F Li Yim, Kenneth L Overberg, Mohammed Ghiboub, Manon E Wildenberg

J Crohns Colitis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity Is Associated with Inferior Clinical Treatment Outcomes in Inflammatory Bowel Disease: A Nationwide Dutch Registry Study.
Dorien Oomkens, Zlatan Mujagic, Annemarie de Vries, Andrea van der Meulen-de Jong, Tessa Straatmijer

Dig Dis Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination.
Laura Yl Kummer, Lisan H Kuijper, Laura Fernández Blanco, Amélie Bos, Christine Kreher

RMD Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease.
Jie Su, Dalia A Lartey, Gaia Zanella, Lukas J A C Hawinkels, Gianluca Matteoli

J Crohns Colitis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib for the treatment of chronic pouchitis: A pilot study.
Djuna C de Jong, Rogier Goetgebuer, Bart L M Müskens, E Andra Neefjes-Borst, Krisztina B Gecse

United European Gastroenterol J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directionality of endoscopic and histologic healing in ulcerative colitis: a prospective pilot study.
Jurij Hanžel, Gregor Novak, Vipul Jairath, Guangyong Zou, Hannah Dong

Eur J Gastroenterol Hepatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAPi PET/CT Imaging to Identify Fibrosis in Immune-Mediated Inflammatory Diseases.
Dalia A Lartey, Lynn A Schilder, Gerben J C Zwezerijnen, Geert R A M D'Haens, Joep Grootjans

Biomedicines· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal Healing With Vedolizumab in Patients With Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled Trial.
Vipul Jairath, Brian G Feagan, Mark S Silverberg, Silvio Danese, Paolo Gionchetti

Clin Gastroenterol Hepatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tryptophan metabolites profile predict remission with dietary therapy in pediatric Crohn's disease.
Rotem Sigall Boneh, Nikki van der Kruk, Eytan Wine, Charlotte M Verburgt, Tim G J de Meij

Therap Adv Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonlinear aeroelastic modelling and analysis of a geometrically nonlinear wing with combined unsteady sectional and lifting line aerodynamics.
Sanuja Jayatilake, Mark Lowenberg, Benjamin K S Woods, Branislav Titurus

Nonlinear Dyn· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic endpoints in biologic clinical trials and beyond: the case for Crohn's Disease.
Marlou P M Adriaanse, Mark Löwenberg, Geert R A M D'Haens

Expert Opin Biol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness and cost-utility of optimized mercaptopurine treatment versus placebo in ulcerative colitis patients: The randomized controlled OPTIC trial.
Mark Löwenberg, Marit van Barreveld, Adriaan Volkers, Sara van Gennep, Marjolijn Duijvestein

United European Gastroenterol J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights and innovations to mitigate aviation climate impact by 2030.
Kieran Tait, Marius Wedemeyer, Anwar Khan, Mark Lowenberg, Dudley Shallcross

Commun Eng· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.
Eileen W Stalman, Luuk Wieske, Jim B D Keijser, Koos P J van Dam, Laura Y L Kummer

J Allergy Clin Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib.
Sara van Gennep, Ivan C N Fung, Djuna C de Jong, Rishand K Ramkisoen, Esmé Clasquin

J Crohns Colitis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of 'IBD-Specific Cognitive Behavioural Therapy' for Patients with Inflammatory Bowel Diseases with Poor Mental Quality of Life, Anxiety and Depression.
Floor Bennebroek Evertsz', Claudi L Bockting, Annemarie Braamse, Mafalda N M van Dissel, Marjolijn Duijvestein

J Clin Psychol Med Settings· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8 T cell responses.
Jet van den Dijssel, Mariël C Duurland, Veronique Al Konijn, Laura Yl Kummer, Ruth R Hagen

J Autoimmun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case series.
Suzanne I Anjie, Krisztina B Gecse, Cyriel Y Ponsioen, Mark Löwenberg, Geert R D'Haens

Therap Adv Gastroenterol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis